Haloperidol Tablet
Product Images NDC 82619-110

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Haloperidol (NDC 82619-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Creekwood Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (90d08b92 Bf4a 4040 B9fa A0c978f0f286 01)

FDA Label Image

0.5 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 02)

FDA Label Image

0.5 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 03)

0.5 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 03)
This is a description of a medication called Haloperidol in tablet form. Each tablet contains 0.5mg of Haloperidol, and there are a total of 1000 tablets in the package. The usual dosage information should be referenced before taking the medication. It is advised to keep this medication out of reach of children and store it at the appropriate temperature range. The manufacturing and distribution details indicate that it is produced in India and distributed by Creekwood Pharmaceuticals in the US. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The issue date is October 2023.*
FDA Label Image

1 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 04)

1 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 04)
This is a detailed description of Haloperidol tablets, USP with a concentration of 1 mg per tablet. The medication is prescribed for use and should be kept out of the reach of children, stored at a temperature between 20° to 25°C. It is important to protect it from light and dispense in a tight, light-resistant container with a child-resistant closure. The medication is manufactured by V-Ensure Pharma Technologies in India and distributed by Creekwood Pharmaceuticals in the US. It is advised to follow the usual dosage and refer to the accompanying prescribing information for further details.*
FDA Label Image

1 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 05)

1 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 05)
This is a description for a medication called Haloperidol in tablet form. Each tablet contains 1 mg of Haloperidol USP. The usual dosage and prescribing information should be consulted before use. The medication should be kept out of reach of children, stored at room temperature, protected from light, and dispensed in a light-resistant container with a child-resistant closure. The product is manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad Maharashtra, India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, New Jersey. The issue date for this information is October 2023.*
FDA Label Image

2 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 06)

2 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 06)
This is a description of a medication called Haloperidol in tablet form, with each tablet containing 2 mg of Haloperidol. The medication is only available with a prescription and is packaged with 100 tablets in a container. It is recommended to store the medication at a temperature between 20°C to 25°C, with excursions permitted to 15°C to 30°C. The packaging should also be protected from light. The medication is manufactured by V-Ensure Pharma Technologies PV, Ltd. in Raigad Maharashtra, India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. The medication should be dispensed in a tight, light-resistant container with a child-resistant closure.*
FDA Label Image

2 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 07)

2 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 07)
This text provides information on a medication containing Haloperidol, USP 2 mg tablets. The tablets are to be dispensed in a tight, light-resistant container with a child-resistant closure, as per USP standards. The usual dosage and prescribing information should be followed. The medication should be stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F), and protected from light. It also mentions the manufacturing license number and expiration date, and details about the distributor.*
FDA Label Image

5 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 08)

5 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 08)
This is a description of a medication called Haloperidol in tablet form. Each tablet contains 5 mg of Haloperidol. The usual dosage instructions are provided in the accompanying prescribing information. The medication should be kept out of the reach of children and stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). It should be protected from light and dispensed in a tight, light-resistant container with a child-resistant closure. The medication is manufactured by V-Ensure Pharma Technologies PV, Ltd. in Raigad Maharashtra, India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. The issue number and license number are also provided.*
FDA Label Image

5 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 09)

5 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 09)
This is a product label for Haloperidol tablets, USP, containing 5 mg of Haloperidol per tablet. The usual dosage instructions are provided in the accompanying prescribing information. The medication should be kept out of reach of children and stored at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). It should be protected from light and dispensed in a tight, light-resistant container with a child-resistant closure. The tablets are manufactured by V-Ensure Pharma Technologies PV, Ltd., in India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ.*
FDA Label Image

5 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 10)

5 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 10)
This is a prescription medicine containing Haloperidol tablets, each tablet having 5 mg of the active ingredient. The usual dosage should be followed as per the accompanying prescribing information. It is advised to keep the medication out of the reach of children, store it at room temperature, protect it from light, and dispense it in a light-resistant container with a child-resistant closure. The medicine is manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in India and distributed by Creekwood Pharmaceuticals LLC in the USA. The issue date of these tablets is October 2023.*
FDA Label Image

10 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 11)

10 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 11)
This is a description of a medication package for Haloperidol tablets, USP. Each tablet contains 10mg of Haloperidol. The package contains 30 tablets for prescription use only. It is advised to keep the medication out of reach of children, store at room temperature, protect from light, and dispense in a tight, light-resistant container. The medication is manufactured in India and distributed in the US.*
FDA Label Image

10 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 12)

10 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 12)
This text provides information on Haloperidol tablets, USP with a concentration of 10 mg. It includes details about the dosage, storage instructions (temperature and light protection), manufacturer details, distribution entity, and packaging requirements. The medication is classified as Rx Only, with 100 tablets per container. Please follow the accompanying prescribing information and keep the medication out of children's reach.*
FDA Label Image

10 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 13)

10 mg 1000 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 13)
This is a product label for Haloperidol tablets, a prescription medication used to treat certain mental and mood disorders. Each tablet contains 10 mg of Haloperidol, USP. The recommended storage conditions are at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be kept in a tight, light-resistant container with a child-resistant closure. The product is distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ, and manufactured by V-Ensure Pharma Technologies Pvt. Ltd. in Raigad, Maharashtra, India.*
FDA Label Image

20 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 14)

20 mg 30 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 14)
This is a description of a medication labeled as Haloperidol tablets, USP, with a strength of 20 mg per tablet. The prescription is for 30 tablets and it is recommended to follow the dosage instructions provided. The medication should be stored at temperatures between 20°C to 25°C with protection from light. The manufacturing company is V-Ensure Pharma Technologies in Raigad, Maharashtra, India, and the distribution is by Creekwood Pharmaceuticals LLC in Parsippany, NJ. It is advised to dispense the tablets in a tight, light-resistant container with a child-resistant closure.*
FDA Label Image

20 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 15)

20 mg 100 Tablets (90d08b92 Bf4a 4040 B9fa A0c978f0f286 15)
This is a description of haloperidol tablets, USP, with each tablet containing 20 mg of haloperidol. The usual dosage information is provided in the accompanying prescribing information. The medication should be kept out of the reach of children and stored at 20°C to 25°C. It should be protected from light and dispensed in a tight, light-resistant container with a child-resistant closure. The tablets are manufactured in Raigad, Maharashtra, India, and distributed by Creekwood Pharmaceuticals LLC in Parsippany, NJ. The expiration date is October 2023.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.